News
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
14d
AZoLifeSciences on MSNMeet Lariocidin: A Game-Changing Antibiotic That Outsmarts ResistanceThe study reveals lariocidin, a potent ribosome-targeting antibiotic, with unique mechanisms that could combat drug-resistant ...
3d
News-Medical.Net on MSNResearchers develop drug cocktail to target enterovirusesEnteroviruses are a group of viruses that cause everything from the common cold to meningitis, polio, type 1 diabetes, and ...
A recent study found that up to 90% of sepsis patients may be overtreated. The study, published April 15 in Clinical Infectious Diseases and led by researchers from Brigham’s Women’s Hospital and ...
1 present a satisfyingly complete account of the discovery and initial characterization of this antibiotic. Read the paper: A broad-spectrum lasso peptide antibiotic targeting the bacterial ...
The results from two newly published randomized clinical trials provide more evidence that a computerized stewardship alert ...
That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective at killing both gram-positive and gram-negative pathogenic bacteria, along ...
The Drmtlgy Broad Spectrum SPF 45 is part of the Sunscreens ... CR’s testing is patterned after the Food and Drug Administration (FDA) test method that sunscreen manufacturers are required ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results